Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Apple Seeks a Way in Court to Keep 2 of Its Best Watches on Shelves During Bitter Patent Dispute
Apple filed an emergency motion seeking court permission to begin selling two of its most popular watches again until a final decision on its broader appeal in a bitter patent dispute is decided.
Christmas Box Office Earnings
Christmas Box Office Earnings
GM Halts Sales of Chevy Blazer EV Over Software Issue
GM Halts Sales of Chevy Blazer EV Over Software Issue
Intel to Build New $25B Chip Factory in Israel
Intel to Build New $25B Chip Factory in Israel
Home Prices Up 4.8 Percent Year-Over-Year in October
Home Prices Up 4.8 Percent Year-Over-Year in October
Powerball Jackpot Reaches $685M
Powerball Jackpot Reaches $685M
Major Holiday Travel Issues Avoided Across U.S.
Major Holiday Travel Issues Avoided Across U.S.
Americans Ramped Up Spending During the Holidays Despite Some Financial Anxiety and Higher Costs
Mastercard SpendingPulse said Tuesday that holiday sales rose this year.
On the Scene: Post-Holiday Shopping at American Dream Mall
New Jersey's American Dream Mall continues to offer holiday experiences.
